Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis
- PMID: 17540857
- DOI: 10.1634/stemcells.2006-0686
Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis
Abstract
Recent reports indicated that vascular remodeling and angiogenesis are promoted by conditioned medium from the cells referred to as multipotent stromal cells (MSCs). However, the molecular events triggered by MSC-conditioned medium (CdM) were not defined. We examined the effects of CdM from human MSCs on cultures of primary human aortic endothelial cells (HAECs). The CdM inhibited hypoxia-induced apoptosis and cell death of HAECs. It also promoted tube formation by HAECs in an assay in vitro. Conditioned medium from multipotent stromal cells incubated under hypoxic conditions in serum-free endothelial basal medium for 2 days (CdM(Hyp)) from hypoxic culture of MSCs was more effective than conditioned medium from MSCs incubated under normoxic conditions in serum-free endothelial basal medium for 2 days from normoxic cultures of MSCs, an observation in part explained by its higher content of antiapoptotic and angiogenic factors, such as interleukin (IL)-6, vascular endothelial growth factor (VEGF), and monocyte chemoattractant protein (MCP)-1. The effects of CdM(Hyp) on hypoxic HAECs were partially duplicated by the addition of IL-6 in a dose-dependent manner; however, anti-IL-6, anti-MCP-1, and anti-VEGF blocking antibodies added independently did not attenuate the effects. Also, addition of CdM(Hyp) activated the PI3K-Akt pathway; the levels of p-Akt and several of its downstream targets were increased by CdM(Hyp), and both the increase in p-Akt and the increase in angiogenesis were blocked by an inhibitor of PI3K-Akt or by expression of a dominant negative gene for PI3K. CdM(Hyp) also increased the levels of p-extracellular signal-regulated kinase (ERK), but there was a minimal effect on p-signal transducer and activator of transcription-3, and an inhibitor of the ERK1/2 pathway had no effect on hypoxia-induced apoptosis of the HAECs. The results are consistent with suggestions that administration of MSCs or factors secreted by MSCs may provide a therapeutic method of decreasing apoptosis and enhancing angiogenesis.
Similar articles
-
Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.J Cell Biochem. 2008 Jan 1;103(1):256-69. doi: 10.1002/jcb.21402. J Cell Biochem. 2008. PMID: 17497701
-
Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.Oncogene. 2009 Sep 24;28(38):3412-22. doi: 10.1038/onc.2009.189. Epub 2009 Jul 13. Oncogene. 2009. PMID: 19597469
-
Stromal cell-secreted factors promote the survival of embryonic stem cell-derived early neural stem/progenitor cells via the activation of MAPK and PI3K-Akt pathways.J Neurosci Res. 2010 Mar;88(4):722-34. doi: 10.1002/jnr.22250. J Neurosci Res. 2010. PMID: 19798745
-
[A new in vitro model to quantify angiogenesis].ALTEX. 2004;21(4):227-44. ALTEX. 2004. PMID: 15586254 Review. German.
-
The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration.Tissue Eng Part B Rev. 2013 Dec;19(6):516-28. doi: 10.1089/ten.TEB.2012.0672. Epub 2013 Jul 10. Tissue Eng Part B Rev. 2013. PMID: 23651329 Review.
Cited by
-
Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression.Int J Mol Sci. 2015 Dec 16;16(12):30015-33. doi: 10.3390/ijms161226215. Int J Mol Sci. 2015. PMID: 26694366 Free PMC article. Review.
-
Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).J Cell Mol Med. 2010 Sep;14(9):2190-9. doi: 10.1111/j.1582-4934.2010.01151.x. J Cell Mol Med. 2010. PMID: 20716123 Free PMC article. Review.
-
Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties.J Cell Mol Med. 2017 Feb;21(2):349-363. doi: 10.1111/jcmm.12969. Epub 2016 Sep 19. J Cell Mol Med. 2017. PMID: 27641937 Free PMC article.
-
Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches.Front Immunol. 2023 Nov 3;14:1280601. doi: 10.3389/fimmu.2023.1280601. eCollection 2023. Front Immunol. 2023. PMID: 38022534 Free PMC article. Review.
-
In Vitro Innovation of Tendon Tissue Engineering Strategies.Int J Mol Sci. 2020 Sep 14;21(18):6726. doi: 10.3390/ijms21186726. Int J Mol Sci. 2020. PMID: 32937830 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous